Table 2.
List of anti-coronavirus peptides (* calculated by APD3 [106]: antimicrobial peptide calculator)
(A) The peptides inhibiting fusion | |||||||||
---|---|---|---|---|---|---|---|---|---|
Peptide | Sequence | Peptide source | Virus | *Net charge | *Hydrophobic residues (%) | Toxicity (TC50)/ selectivity index (SI) | IC50 | Cell line/animal model | References |
SARSWW-III | GYHLMSFPQAAPHGVVFLHVTW | S2 subunit of SARS-CoV | SARS-CoV | 0 | 50 | No difference in absorbance as compared to untreated cells | ∼2 μM | Vero E6 and L2 cells | [96] |
SARSWW-IV | GVFVFNGTSWFITQRNFFS | S2 subunit of SARS-CoV | SARS-CoV | 1 | 47 | No difference in absorbance as compared to untreated cells | ∼2 μM | Vero E6 and L2 cells | [96] |
MHVWW-IV | GYFVQDDGEWKFTGSSYYY | S2 subunit of MHV | MHV | −2 | 21 | Not cytotoxic at a concentration of 30 μM on L2 cells | 4 μM | Vero E6 and L2 cells | [96] |
P1 | LTQINTTLLDLTYEMLSLQQVVK ALNESYIDLKEL |
HR2 region of MERS-CoV | MERS-CoV | −3 | 42 | – | ∼3.013 μM | 293T | [104] |
HR2L | SIPNFGSLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKELGNY | HR2 region of MERS-CoV | MERS-CoV | −3 | 37 | – | 0.5 μM | 293T/EGFP + Huh-7 cells | [94] |
HR2P | SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL | HR2 region of MERS-CoV | MERS-CoV | −3 | 41 | SI = CC50/IC50 > 1667 | 0.97 ± 0.15 μM | 293T/EGFP + Huh-7 cells | [94] |
HR2P-M1 | SLTQINTTLLDLEYEMRSLQQVVKALNESYIDLKEL | HR2P region of MERS-CoV | MERS-CoV | −3 | 38 | – | 0.85 ± 0.08 μM | 293T/EGFP + Huh-7 cells | [94] |
HR2P-M2 | SLTQINTTLLDLEYEMKKLEEVVKKLEESYIDLKEL | HR2 region of MERS-CoV | MERS-CoV | −4 | 36 | – | 0.55 ± 0.04 μM | 293T cells and Huh-7 cells | [105] |
P9 | NGAICWGPCPTAFRQIGNCGHFKVRCCKIR | Mouse β-defensin-4 | SARS-CoV MERS-CoV | 5 | 46 | Low toxicity in vivo | 5 μg/ml | Mice | [99] |
(B) The peptides inhibiting viral replication | |||||||||
---|---|---|---|---|---|---|---|---|---|
Peptide | Sequence | Peptide source | Virus | *Net charge | *Hydrophobic residues (%) | Toxicity (TC50) selectivity index (SI) | IC50 | Cell lines/ animal model | Reference |
K29 | FGGASCCLYCRCHIDHPNPKGFCDLKGKY | nsp10 of SARS-CoV | SARS-CoV | 2 | 37 | – | 160 μM | E. coli | [102] |
K12 | GGASCCLYCRCH | nsp10 of SARS-CoV | SARS-CoV | 1 | 50 | – | 160 μM | E. coli | [102] |
HR2P | SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL | HR2 region of MERS-CoV | MERS-CoV | −3 | 41 | SI > 1667 | ∼0.6 μM | Vero cells | [94] |
HR2P | SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL | HR2 region of MERS-CoV | MERS-CoV | −3 | 41 | SI > 1667 | 0.6 μM | Calu-3 cells | [94] |
HR2P | SLTQINTTLLDLTYEMLSLQQVVKALNESYIDLKEL | HR2 region of MERS-CoV | MERS-CoV | −3 | 41 | – | 13.9 Μm | HFL cells | [94] |
Mutant mucroporin-M1 | LFRLIKSLIKRLVSAFK | Mucropin AMP | SARS-CoV | 5 | 58 | TC50 = 70.46 SI = 9.85 |
7.15 μg/ml | MDCK | [101] |
(C) The peptides inhibiting virus entry (KD: peptide’s dissociation constant) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Peptide | Sequence | Peptide source | Virus | *Net charge | *Hydrophobic residues (%) | Toxicity (TC50) selectivity index (SI) | IC50 | Cell lines/animal model | Reference |
H | HVTTTFAPPPPR | Porcine aminopeptidase N (pAPN) of TGEV | TGEV | 1 | 25 | 0.55 (490 nm) | 11 μg/ml | ST | [107] |
S | SVVPSKATWGFA | Papn of TGEV | 1 | 50 | 0.5 (490 nm) | 15 μg/ml | ST | [107] | |
RBD-11b | YKYRYL | RBD of SARS-CoV | SARS-CoV | 2 | 16 | No evidence for toxicity | KD = 46 μM | Vero E6 | [108] |
P8 | PSSKRFQPFQQFGRDVSDFT | S protein of SARS-CoV | SARS-CoV | 1 | 25 | – | – | HEK293T | [109] |
P9 | CANLLLQYGSFCTQLNRAL SGIA |
S protein of SARS-CoV | SARS-CoV | 1 | 52 | – | – | HEK293T | [109] |